{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:48:10Z","timestamp":1783633690275,"version":"3.55.0"},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T00:00:00Z","timestamp":1346889600000},"content-version":"vor","delay-in-days":3140,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Obesity Research"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective<\/jats:italic>: To compare the efficacy of different weight loss regimens on body weight loss and metabolic improvement in breast cancer survivors.<\/jats:p><jats:p><jats:italic>Research Methods and Procedures<\/jats:italic>: Forty\u2010eight obese breast cancer survivors were randomly divided into four groups and were followed for 1 year: 1) the Control group (subjects did not receive specific nutrition counseling); 2) the Weight Watchers group (subjects were given free coupons to attend weekly Weight Watchers meetings); 3) the Individualized group (a registered dietitian provided one\u2010on\u2010one nutritional counseling); and 4) the Comprehensive group (subjects received individualized dietary counseling and free coupons for the weekly Weight Watchers meetings). At baseline and 3\u2010, 6\u2010, and 12\u2010month data collection visits, a fasting blood sample was obtained for assays. A three\u2010day dietary record was kept during the week before these visits and dietary intake was analyzed.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>: Subjects in the three intervention groups lost weight (Control: 1.1 \u00b1 1.7 kg; Weight Watchers: \u22122.7 \u00b1 2.1 kg; Individualized: \u22128.0 \u00b1 1.9 kg; Comprehensive: \u22129.5 \u00b1 2.7 kg) and percentage body fat, but only the Individualized and Comprehensive groups had significant losses. Subjects in the Comprehensive group showed the most improvement in cholesterol levels and had reductions in blood leptin levels.<\/jats:p><jats:p><jats:italic>Discussion<\/jats:italic>: Because insulin resistance and high blood leptin levels are associated with breast cancer, losing weight to improve these parameters may reduce the risk of recurrence. Only subjects in the Comprehensive group showed significant reductions in body weight and fat, energy intake, and leptin levels. For breast cancer survivors, different weight loss strategies should be considered to assist them in losing weight.<\/jats:p>","DOI":"10.1038\/oby.2004.38","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T09:00:27Z","timestamp":1208768427000},"page":"306-312","source":"Crossref","is-referenced-by-count":49,"title":["Improvement of Metabolism among Obese Breast Cancer Survivors in Differing Weight Loss Regimens"],"prefix":"10.1002","volume":"12","author":[{"given":"K.\u2010L. Catherine","family":"Jen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Djuric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora M.","family":"DiLaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Buison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer N.","family":"Redd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Maranci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Hryniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,9,6]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.10.1195"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00006"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441801"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-2-200007180-00008"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1212032"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801094"},{"key":"e_1_2_7_8_2","first-page":"25","article-title":"Weight reduction by fasting and semistarvation in morbid obesity: long term follow\u2010up","volume":"2","author":"Drenick E.","year":"1978","journal-title":"Int J Obes"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801374"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.73"},{"key":"e_1_2_7_11_2","doi-asserted-by":"crossref","first-page":"437S","DOI":"10.1093\/ajcn\/63.3.437","article-title":"Body weight: an estimation of risk for breast and endometrial cancers","volume":"63","author":"Ballard\u2010Barbash R.","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940801)74:3 <1090::AID-CNCR2820741518>3.0.CO;2-X"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-199305000-00007"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005942017626"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.1.42"},{"key":"e_1_2_7_16_2","first-page":"40","article-title":"Diabetes but not obesity is a prognostic factor for disease free survival (DFS) in women with stage I, II and III breast carcinoma receiving Tamoxifen","volume":"64","author":"Song E.","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2002.89"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01806141"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2001.00134.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.4.1128"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-200102000-00003"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(00)00200-9"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/101053959400700204"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01831377"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00051352"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/15353702-0322807-01"},{"key":"e_1_2_7_29_2","first-page":"681","article-title":"Lipoprotein alterations, abdominal fat distribution and breast cancer","volume":"47","author":"Schreier L.","year":"1999","journal-title":"Biochem Mol Biol Int"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005990070013"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(94)90008-6"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2744(200001)27:1<2::AID-MC2>3.0.CO;2-W"},{"key":"e_1_2_7_33_2","first-page":"483","article-title":"Association between high\u2010density lipoprotein cholesterol and breast cancer varies by menopausal status","volume":"7","author":"Moorman P.","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-2942-2_17"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(00)00160-0"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000028062"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.9.2381"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1079\/PHN2001124"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8223(98)00263-6"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01464-8"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.83.10.1059"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5383.1683"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00205-X"},{"key":"e_1_2_7_44_2","first-page":"421","article-title":"Leptin expression in colorectal and breast cancer patients","volume":"5","author":"Tessitore L.","year":"2000","journal-title":"Int J Mol Med"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.11.1455"}],"container-title":["Obesity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Foby.2004.38","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1038\/oby.2004.38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:50:04Z","timestamp":1698735004000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1038\/oby.2004.38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1038\/oby.2004.38"],"URL":"https:\/\/doi.org\/10.1038\/oby.2004.38","archive":["Portico"],"relation":{},"ISSN":["1071-7323","1550-8528"],"issn-type":[{"value":"1071-7323","type":"print"},{"value":"1550-8528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}